Chattanooga Times Free Press

My ‘decision to make’: Trump defends criticized use of drug

- BY ZEKE MILLER, MARILYNN MARCHIONE AND JONATHAN LEMIRE

WASHINGTON — President Donald Trump emphatical­ly defended himself Tuesday against criticism from medical experts that his announced use of a malaria drug against the coronaviru­s could spark wide misuse by Americans of the unproven treatment with potentiall­y fatal side effects.

Trump’s revelation a day earlier that he was taking hydroxychl­oroquine caught many in his administra­tion by surprise and set off an urgent effort by officials to justify his action. But their attempt to address the concerns of health profession­als was undercut by the president himself.

He asserted without evidence that a study of veterans raising alarm about the drug was “false” and an “enemy statement,” even as his own government warned that the drug should be administer­ed for COVID-19 only in a hospital or research setting.

“If you look at the one survey, the only bad survey, they were giving it to people that were in very bad shape,” Trump said. That was an apparent reference to a study of hundreds of patients treated by the Department of Veterans Affairs in which more of those in a group who were administer­ed hydroxychl­oroquine died than among those who weren’t.

“They were very old. Almost dead,” Trump said. “It was a Trump enemy statement.” During a Cabinet meeting, he elicited a defense of his practice from other officials, including VA Secretary David Wilkie who noted that the study in question was not conducted by his agency.

But the drug has not been shown to combat the virus in a multitude of other studies as well. Two large observatio­nal studies, each involving around 1,400 patients in New York, recently found no COVID benefit from hydroxychl­oroquine. Two new ones published last week in the medical journal BMJ reached the same conclusion.

Trump said he decided

“… at this point in time there’s absolutely no evidence that this strategy works.”

— DR. CARLOS DEL RIO, INFECTIOUS DISEASE SPECIALIST AT EMORY UNIVERSITY IN ATLANTA

to take hydroxychl­oroquine after two White House staffers tested positive for the disease, but he already had spent months promoting the drug as a potential cure or preventive despite the cautionary advice of many of his administra­tion’s top medical profession­als.

“This is an individual decision to make,” Trump told reporters during a visit to Capitol Hill to meet with Senate Republican­s.

He later claimed, “It’s gotten a bad reputation only because I’m promoting it.”

Many studies are testing hydroxychl­oroquine for preventing or limiting coronaviru­s illness but “at this point in time there’s absolutely no evidence that this strategy works,” said Dr. Carlos del Rio, an infectious disease specialist at Emory University in Atlanta.

“My concern is, the president has a big bully pulpit … maybe people will think there’s some non-public evidence” that the drug works because Trump has chosen to use it, del Rio said. “It creates this conspiracy theory that something works and they’re not telling me about it yet.”

 ?? AP PHOTO/EVAN VUCCI ?? President Donald Trump speaks during a Tuesday event on the food supply chain during the coronaviru­s pandemic, in the Roosevelt Room of the White House.
AP PHOTO/EVAN VUCCI President Donald Trump speaks during a Tuesday event on the food supply chain during the coronaviru­s pandemic, in the Roosevelt Room of the White House.

Newspapers in English

Newspapers from United States